Quantitative structure-activity relationship studies on some anticancerous, antiviral and cytostatic agents. 1989

C Pandey, and K P Dwivedi, and G D Yadava, and V K Singh, and A K Srivastava, and V K Agrawal

QSAR studies using molecular connectivity and van der Waal volume have been performed on a new series of hydroxyguanidine derivatives and a series of isoindolediones. Regression analysis has shown that anticancer and antiviral activity of hydroxyguanidines as well as cytostatic activity of isoindolediones correlate well with both the structural parameters.

UI MeSH Term Description Entries
D002627 Chemistry, Physical The study of CHEMICAL PHENOMENA and processes in terms of the underlying PHYSICAL PHENOMENA and processes. Physical Chemistry,Chemistries, Physical,Physical Chemistries
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D055598 Chemical Phenomena The composition, structure, conformation, and properties of atoms and molecules, and their reaction and interaction processes. Chemical Concepts,Chemical Processes,Physical Chemistry Concepts,Physical Chemistry Processes,Physicochemical Concepts,Physicochemical Phenomena,Physicochemical Processes,Chemical Phenomenon,Chemical Process,Physical Chemistry Phenomena,Physical Chemistry Process,Physicochemical Phenomenon,Physicochemical Process,Chemical Concept,Chemistry Process, Physical,Chemistry Processes, Physical,Concept, Chemical,Concept, Physical Chemistry,Concept, Physicochemical,Concepts, Chemical,Concepts, Physical Chemistry,Concepts, Physicochemical,Phenomena, Chemical,Phenomena, Physical Chemistry,Phenomena, Physicochemical,Phenomenon, Chemical,Phenomenon, Physicochemical,Physical Chemistry Concept,Physicochemical Concept,Process, Chemical,Process, Physical Chemistry,Process, Physicochemical,Processes, Chemical,Processes, Physical Chemistry,Processes, Physicochemical

Related Publications

C Pandey, and K P Dwivedi, and G D Yadava, and V K Singh, and A K Srivastava, and V K Agrawal
August 2021, Microorganisms,
C Pandey, and K P Dwivedi, and G D Yadava, and V K Singh, and A K Srivastava, and V K Agrawal
September 2008, Bioorganic & medicinal chemistry,
C Pandey, and K P Dwivedi, and G D Yadava, and V K Singh, and A K Srivastava, and V K Agrawal
January 1997, Journal of enzyme inhibition,
C Pandey, and K P Dwivedi, and G D Yadava, and V K Singh, and A K Srivastava, and V K Agrawal
December 2004, Journal of molecular modeling,
C Pandey, and K P Dwivedi, and G D Yadava, and V K Singh, and A K Srivastava, and V K Agrawal
January 2004, Molecular diversity,
C Pandey, and K P Dwivedi, and G D Yadava, and V K Singh, and A K Srivastava, and V K Agrawal
January 2015, Bioorganic & medicinal chemistry letters,
C Pandey, and K P Dwivedi, and G D Yadava, and V K Singh, and A K Srivastava, and V K Agrawal
August 1992, Journal of medicinal chemistry,
C Pandey, and K P Dwivedi, and G D Yadava, and V K Singh, and A K Srivastava, and V K Agrawal
January 1957, Voprosy onkologii,
C Pandey, and K P Dwivedi, and G D Yadava, and V K Singh, and A K Srivastava, and V K Agrawal
January 2002, Current pharmaceutical design,
C Pandey, and K P Dwivedi, and G D Yadava, and V K Singh, and A K Srivastava, and V K Agrawal
December 2007, Indian journal of biochemistry & biophysics,
Copied contents to your clipboard!